Birgitta Trolle

ORCID: 0009-0005-3366-4879
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian function and disorders
  • Gynecological conditions and treatments
  • Reproductive Biology and Fertility
  • Lipid metabolism and disorders
  • Female Genital Mutilation/Cutting Issues
  • Folate and B Vitamins Research
  • Anesthesia and Pain Management
  • Growth Hormone and Insulin-like Growth Factors
  • Endometriosis Research and Treatment
  • Musculoskeletal pain and rehabilitation
  • Spine and Intervertebral Disc Pathology
  • Uterine Myomas and Treatments
  • Hormonal and reproductive studies
  • Iron Metabolism and Disorders
  • Ovarian cancer diagnosis and treatment
  • Urologic and reproductive health conditions
  • Liver Disease Diagnosis and Treatment
  • Reproductive System and Pregnancy
  • Gestational Diabetes Research and Management
  • Ectopic Pregnancy Diagnosis and Management
  • Trace Elements in Health
  • Hops Chemistry and Applications
  • Assisted Reproductive Technology and Twin Pregnancy
  • Immunodeficiency and Autoimmune Disorders
  • Reproductive tract infections research

Aalborg University Hospital
1991-2024

Aarhus University Hospital
2007-2018

Aarhus University
2008

Regionshospitalet Herning
2008

Regional Hospital Holstebro
2001-2007

Inland Hospital
1992

Regional Hospital Horsens
1991

Kolding Hospital
1989

What is the prevalence of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome?The MRKH syndrome in Denmark 1 4982 (95% confidence interval (CI): 4216-5887) live female births.The has been estimated to be around 4000-5000 females. However, population-based studies are sparse. Moreover, data on patient characteristics lacking.This retrospective cohort study used Danish National Patient Registry (DNPR) identify a nationwide patients with syndrome. Subsequently, were linked Cytogenetic Central (DCCR)...

10.1093/humrep/dew220 article EN Human Reproduction 2016-09-08

10.1016/s0015-0282(01)01909-4 article EN publisher-specific-oa Fertility and Sterility 2001-08-01

Our aim was to assess the effects of metformin on menstrual frequency, fasting plasma glucose (FPG), insulin resistance assessed as HOMA-index, weight, waist/hip ratio, blood pressure (BP), serum lipids, and testosterone levels in women with polycystic ovary syndrome (PCOS) METHODS: In a randomized, controlled, double-blinded setup, 56 aged 18-45 PCOS were treated either 850 mg or placebo twice daily for 6 months. After wash-out period 3 months participants received alternate treatment The...

10.1093/humrep/dem271 article EN Human Reproduction 2007-09-01

Study objectiveThe diagnosis of Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome is often a lengthy process that typically occurs during late adolescence. To support optimized and patient-centered care, this study aimed to investigate how women with MRKH experience the diagnostic process.MethodsFrom January 2021 March 2021, we conducted in-depth interviews 18 Danish (≥25 years) diagnosed syndrome. The lasted median 92 minutes (range: 67-117). Data were analyzed using thematic...

10.1016/j.jpag.2024.03.003 article EN cc-by Journal of Pediatric and Adolescent Gynecology 2024-03-15

10.1016/0002-9378(91)90699-r article EN American Journal of Obstetrics and Gynecology 1991-05-01

Treatment with the anti-diabetic drug metformin is followed by a decline in plasma cobalamin, but it unsettled whether this denotes an impaired cobalamin status. This study has explored changes markers of status women Polycystic Ovary Syndrome treated (1.5–2.5 g per day) (n = 29) or placebo 23) for six months. Serum samples were collected before and after two, four, months treatment. We found serum to reach significant lower levels treatment (p 0.003). Despite we observed no reductions...

10.3390/nu5072475 article EN Nutrients 2013-07-05

As immune globulin anti‐D given in the immediate post partum period fails to prevent development of antibodies about 1.5–2% women at risk, probably as a result feto‐maternal bleeding during pregnancy, 300 μ g was administered 609 Rh‐negative 28th gestational week. Three hundred and forty‐six had Rh‐positive babies, were additionally 200 partum. Of these, 291 an antibody screen test done 10 months after delivery. No found. The results study group compared with those control 354 who did not...

10.3109/00016348909087688 article EN Acta Obstetricia Et Gynecologica Scandinavica 1989-01-01

192 pregnant women were consecutively randomized to either a vitamin‐mineral pill or vitamin mineral with high iron content in prospective, open, investigation. The participants advised about iron‐rich foodstuffs twice during pregnancy. Iron status of the mother proved be without any significance for outcome A serum ferritin level 80 pmol/l mid‐pregnancy followed by control last trimester was suggested as guide deciding whether not prescribe supplementary

10.3109/00016349109006169 article EN Acta Obstetricia Et Gynecologica Scandinavica 1991-01-01

Laparoscopic ovarian drilling (LOD) is used as a first line of treatment, second treatment after patients have proved resistant to clomiphene or third failed ovulation induction with gonadotropins. We present the postoperative pregnancy rates 57 women evaluate potential optimal time LOD together other regimens infertile polycystic ovary syndrome (PCOS). Data on preoperative and operative background data were evaluated for their influence rates. The rate was 61% among PCOS who had LOD. No...

10.1080/09513590410001667869 article EN Gynecological Endocrinology 2004-01-01

Conclusions on the effect of metformin circulating anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS) are ambiguous. We performed a secondary analysis randomized, double-blind, placebo-controlled cross-over trial. Fifty-six hyperandrogenemic PCOS were included. Each woman served as her own control receiving daily dose either 1700 mg or placebo for 6 months. After 3-month wash-out period they received opposite treatment. The decrease AMH from median 49.5 to...

10.1111/aogs.12605 article EN Acta Obstetricia Et Gynecologica Scandinavica 2015-02-07

Abstract Objective To explore how women with Mayer–Rokitansky–Küster–Hauser (MRKH) syndrome experience dilation or surgical vaginal lengthening treatment, and their current sexual well‐being. Design A qualitative interview study. Setting Denmark. Population Women aged ≥25 years diagnosed MRKH syndrome. Methods Semi‐structured video interviews were conducted 18 women. Interviews lasted a median of 92 min digitally recorded, transcribed anonymised. Data analysed using thematic analysis. Main...

10.1111/1471-0528.17916 article EN cc-by-nc BJOG An International Journal of Obstetrics & Gynaecology 2024-07-22

A case of laparoscopic reversal tubal sterilization is reported. The patient was a 38 year old woman sterilized by bipolar diathermia two years earlier. Refertilization performed end to anastomosis one tube. Postoperatively. the had menstruation and then achieved an intrauterine pregnancy. method refertilization saves expensive hospitalization costs.

10.3109/00016349309021166 article EN Acta Obstetricia Et Gynecologica Scandinavica 1993-11-01

Metformin treatment for polycystic ovary syndrome (PCOS) reportedly has had favorable effects on menstrual pattern and infertility, a recent meta-analysis concluded that it is an effective anovulation in affected women. This study examined the of metformin wide range outcomes 56 women ranging age from 18 to 45 years with PCOS. Participants received either dose 850 mg twice daily or placebo 6 months and, after 3-month washout period, alternate another months. In addition intention-to-treat...

10.1097/01.ogx.0000300471.31456.ea article EN Obstetrical & Gynecological Survey 2008-02-01

Women with polycystic ovary syndrome (PCOS) are reported to be at risk for glucose intolerance. The aim of the study was describe these factors in a population Danish PCOS women attending gynecologic clinic and identify parameters strongest correlation fasting blood levels. In addition, we studied whether oral tolerance test (OGTT) diagnosed more cases intolerance this than plasma value (FPG) alone.Cross-sectional 91 oligomenorrhea or amenorrhea elevated serum testosterone, followed by an...

10.1111/j.0001-6349.2005.00627.x article EN Acta Obstetricia Et Gynecologica Scandinavica 2005-11-16

Background. Women with polycystic ovary syndrome (PCOS) are reported to be at risk for glucose intolerance. The aim of the study was describe these factors in a population Danish PCOS women attending gynecologic clinic and identify parameters strongest correlation fasting blood levels. In addition, we studied whether oral tolerance test (OGTT) diagnosed more cases intolerance this than plasma value (FPG) alone. Methods. Cross-sectional 91 oligomenorrhea or amenorrhea elevated serum...

10.1080/j.0001-6349.2005.00627.x article EN Acta Obstetricia Et Gynecologica Scandinavica 2005-01-01

Polycystic ovary syndrome (PCOS) affects 5–10% of women fertile age and most are diagnosed with the because gynecologic symptoms, that is infertility, menstrual disturbances or symptoms hyperandrogenism such as acne excess hair growth. Since report by Burghen et al. (1) in 1980 PCOS was associated hyperinsulinemia, it has become clear more insulin resistant than weight-matched without (2). several features common metabolic syndrome, including dyslipi-demia, abdominal obesity resistance. In...

10.1080/00016340600613352 article EN Acta Obstetricia Et Gynecologica Scandinavica 2006-07-01

Glasier Anna and Gebbie Ailsa, editors: Handbook of Family Planning Reproductive Healthcare, 5th edition, 448 pages. Churchill Livingstone, N 2007. ISBN 9780443068874. Price €44.99/GBP 24.99. In his foreword, John Guillebaud stresses the importance subject this book by quoting James Grant UNICEF, who in 1992 declared that "family planning could bring more benefits to people at less cost than any other single technology now available human race". More half a million women die each year from...

10.1080/00016340801963077 article EN Acta Obstetricia Et Gynecologica Scandinavica 2008-02-28
Coming Soon ...